Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

KM Eriksson, B Markevärn, A Lübking, H Vestergaard… - Leukemia, 2016 - nature.com
Dasatinib (DAS) and interferon-α have antileukemic and immunostimulatory effects and
induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly …
被引用次数：80 相关文章

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

H Hjorth-Hansen, J Stentoft, J Richter… - …, 2016 - portal.research.lu.se
Dasatinib (DAS) and interferon-α have antileukemic and immunostimulatory effects and
induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly …

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

H Hjorth-Hansen, J Stentoft, J Richter… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Dasatinib (DAS) and interferon-α have antileukemic and immunostimulatory effects and
induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly …

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

H Hjorth-Hansen, J Stentoft, J Richter… - Leukemia, 2016 - research.regionh.dk
Dasatinib (DAS) and interferon-α have antileukemic and immunostimulatory effects and
induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly …

Safety and efficacy of the combination of pegylated interferon-[alpha] 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

H Hjorth-Hansen, J Stentoft, J Richter, P Koskenvesa… - Leukemia, 2016 - go.gale.com
Dasatinib (DAS) and interferon-[alpha] have antileukemic and immunostimulatory effects
and induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly …

Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

H Hjorth-Hansen, J Stentoft, J Richter, P Koskenvesa… - Leukemia, 2016 - diva-portal.org
Dasatinib (DAS) and interferon-a have antileukemic and immunostimulatory effects and
induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly …

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Nordic CML Study Group - Leukemia, 2016 - portal.findresearcher.sdu.dk
Dasatinib (DAS) and interferon-α have antileukemic and immunostimulatory effects and
induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly …

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients.

H Hjorth-Hansen, J Stentoft, J Richter, P Koskenvesa… - Leukemia, 2016 - europepmc.org
Dasatinib (DAS) and interferon-α have antileukemic and immunostimulatory effects and
induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly …

[引用][C] Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

H Hjorth-Hansen, J Stentoft, J Richter… - …, 2016 - researchportal.helsinki.fi
Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly
diagnosed chronic-phase chronic myeloid leukemia patients — University of Helsinki Skip to …
[PDF] researchgate.net

[PDF][PDF] Safety and Efficacy of the Combination of Pegylated Interferon–α2b and Dasatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

H Hjorth-Hansen, J Stentoft, J Richter, P Koskenvesa… - 2016 - researchgate.net
Dasatinib (DAS) and interferon-α have antileukemic and immunostimulatory effects and
induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly …